Publications

Human lymphoblastoid IFN suppressed human polyclonal Ig synthesis in a dose-related manner, with 71% mean inhibition of antibody production found when 1000 units of IFN were added to the cultures. This suppression was demonstrated to be mediated by an electrophoretically pure preparation of IFN. Furthermore, IFN inhibition of both the T-dependent and the T-independent polyclonal activators was not the result of direct cellular cytotoxicity. IFN-mediated suppression of human polyclonal Ig production does not result from induction of T suppressor cells, and in a T helper cell-independent system this inhibition appears to result from either a direct action on the B cells or an indirect effect via monocytes.

CTC-SISS-B is an antigen-nonspecific suppressive lymphokine elaborated by an interleukin 2-dependent suppressor T cell line that produces noncytotoxic inhibition of human B cell but not T cell function. Like SISS-B, a soluble suppressive lymphokine present in the supernatants of Con A-activated peripheral blood T cell cultures, CTC-SISS-B is of 60,000 to 90,000 m.w., and its action is blocked by the simple sugar L-rhamnose. CTC-SISS-B inhibits human B cell Ig production and proliferation through a direct interaction with human B cells rather than through indirect effects on immunoregulatory T cells or monocytes. CTC-SISS-B suppression occurs through inhibition of an early event(s) in B cell activation since proliferation and Ig production by established human B cell lines are not inhibited by this lymphokine. Despite sharing many biochemical and biologic properties, CTC-SISS-B and gamma-interferon appear to be distinct mediators.